Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 3, 2012

View Archived Issues

Plant-based platform developed for production of antimalarial drug

Takeda identifies benzazepine derivatives for treatment of obesity

Selective GlyT2 inhibitor shows promising analgesic effects in vivo

Mochida reports potent in vivo analgesic activity for proprietary drug

European team generates water-stable, helicate-like products as potential antimicrobials

Oleanolic acid derivative shows promise in model of MS

New panthetheinase inhibitors presented to treat malaria

Exonhit discloses novel tubulin polymerization inhibitors

Boehringer Ingelheim synthesizes novel chemokine CCR2 receptor antagonists

GlaxoSmithKline enrolling toddlers in phase I pneumococcal vaccine trial

Recruitment begins in phase III BEACON study

New phosphodiesterase inhibitors prepared at IntraCellular Therapies

Cardiolynx patents new pioglitazone derivatives

Novel peptide conjugates for bacterial infections designed in Canada

Lundbeck launches antiepileptic tablet in U.S.

Resubmitted pixantrone NDA to be reviewed by FDA's ODAC

New alpha-glucosidase inhibitors developed in Spain

Phase IIb trial of photodynamic therapy for cervical intraepithelial neoplasia advances

Phylogica enters new collaboration involving Phylomer peptide platform

Enrollment in phase II KRN-321 study begins in Japan

Agile Therapeutics completes phase III program for contraceptive patch

Advaxis to raise additional funding with sale of convertible promissory notes

Tivozanib superior to sorafenib in phase III study

Alnylam reports encouraging preclinical data on RNAi therapeutic for Huntington's disease

Glenmark begins pivotal study of antidiarrheal drug in India

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...